Contracts › 75N91024F00001
75N91024F00001: The Scope of This Task Order Is (1). Production of a Drug Substance, (2) Conversion of Drug Substance to Drug Product, (3) Filling Drug Product Into Applicators to Be Used in the Clinical Trials, and (4) Production of a Placebo Product.
Awarded to Mriglobal by National Institutes of Health (NIH).
$1.9Mobligated
$1.9Mpotential value
17 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91024F00001 |
|---|---|
| Vehicle | 75N91023D00010 |
| Awardee | Mriglobal |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NIH NCI |
| NAICS | 541690 Other Scientific and Technical Consulting Services |
| PSC | Q301 Reference Laboratory Testing |
| Place of performance | MO |
| Period of performance | 18 September 2024 to 17 September 2026 |
| Potential end | 17 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541690 contracts · All expiring contracts · USASpending record